淡江大學機構典藏:Item 987654321/118636
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 62830/95882 (66%)
造访人次 : 4066835      在线人数 : 781
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library & TKU Library IR team.
搜寻范围 查询小技巧：
  • 您可在西文检索词汇前后加上"双引号"，以获取较精准的检索结果
  • 若欲以作者姓名搜寻，建议至进阶搜寻限定作者字段，可获得较完整数据
    •  进阶搜寻


    jsp.display-item.identifier=請使用永久網址來引用或連結此文件: https://tkuir.lib.tku.edu.tw/dspace/handle/987654321/118636


    题名: Statin Use in Cirrhotic Patients with Infectious Diseases: A Population-based Study
    作者: Tsung-Hsing Hung;Chih-Chun Tsai;Hsing-Feng Lee
    日期: 2019-04-24
    上传时间: 2020-06-01 12:10:38 (UTC+8)
    出版者: Public Library of Science
    摘要: Background
    Recent studies have shown benefits of statins in patients with liver cirrhosis. However, it is
    still unknown if statins have a beneficial effect on the mortality of cirrhotic patients with bacterial infections.
    Methods
    The Taiwan National Health Insurance Database was searched, and 816 cirrhotic patients
    receiving statins with bacterial infections hospitalized between January 1, 2010 and December 31, 2013 were included in the study. A one-to-four propensity score matching was performed to select a comparison group based on age, sex, and comorbid disorders.
    Results
    The overall 30-day mortalities in statin and non-statin group were 5.3% and 9.8%, respectively (P = 0.001). After Cox regression modeling adjusting for age, sex, and comorbid disorders, the hazard ratio (HR) of statin use on 30-day mortality was 0.52 (95% confidence
    interval [CI]: 0.38–0.72, P<0.001). In subgroup analysis, the 30-day mortality effect of statin
    use was more pronounced in patients with pneumonia (HR = 0.34; 95% CI: 0.19–0.59;
    P<0.001) and bacteremia (HR = 0.55; 95% CI: 0.35–0.85; P = 0.008). Atovastatin (HR =
    0.59; 95% CI: 0.37–0.93) and rosuvastatin (HR = 0.59; 95% CI: 0.36–0.98) were associated
    with a decreased 30-day mortality risk compared to patients not taking statins.
    Conclusions
    Statin use decreases the 30-day mortality of cirrhotic patients with bacteremia and
    pneumonia.
    關聯: PLoS One 14(4), e0215839
    DOI: 10.1371/journal.pone.0215839
    显示于类别:[數學學系暨研究所] 期刊論文

    文件中的档案:

    档案 描述 大小格式浏览次数
    index.html0KbHTML65检视/开启
    Statin Use in Cirrhotic Patients with Infectious Diseases A Population-based Study.pdf533KbAdobe PDF1检视/开启

    在機構典藏中所有的数据项都受到原著作权保护.

    TAIR相关文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library & TKU Library IR teams. Copyright ©   - 回馈